Slideshows

Retatrutide, survodutide, orforglipron. The 3 new GLP-1 agonist-based AOMs showed weight loss of up to 20% and are well worth watching.

Is there evidence to support hypnosis for pediatric pain? A new review examined available studies to find out.

Try this 7-question quiz on the 2023 guidelines from The Endocrine Society that focus on advances in diabetes treatment that help minimize risk of hypoglycemia.

A new data brief from the NCHS examined the characteristics of US adults who did not take medication as prescribed to reduce costs. A breakdown of the results, here.

Prescriptions for continuous glucose monitoring for patients with T2D are increasing, a new study finds, and the authors report on characteristics of new CGM users.

The Endocrine Society's first update on management of hypoglycemia since 2009 emphasizes the value of new technology and therapeutics in minimizing risk.

A recent CDC report showed that approximately 20% of Americans experienced chronic pain in 2021 and certain groups were most vulnerable. Details in our new slideshow.

Women's Health Week (May 14-20, 2023) is an ideal opportunity to review the top research, policy shifts, and potential drug approvals that affect your patient panel.

Which state has the highest percentage of teenage drug users? Or the fewest opioid prescriptions? Answers from a new report, here.

New survey of older adults shows the majority are open to stopping at least 1 of their medications—but some who already did so didn't consult their clinician first.

The updated American College of Physicians osteoporosis treatment guideline is summarized in this topline review for primary care clinicians.

The US health care provider community continues to do its collective best to cope with the protean condition that is long COVID, according to recent poll findings.

Which US city has the lowest percentage of physically active adults? Which has the highest cost of medical visits? Answers and more categories, here.

Use of opioids to manage chronic pain is not preferred but the VA/DoD make specific new recommendations on how to proceed. Try 8 questions on the guidelines.

Migraine disproportionately affects women, a disparity typically ascribed to hormonal differences. A new study takes a new look at the issue.

Updated VA/DoD chronic pain management guidelines include recommendations for dual use of buprenorphine and increased mental health assessment before prescribing opioids.

For each of the 6 biologic agents FDA-approved for severe asthma, find the mechanism of action, indication, and biomarkers that predict enhanced response.

From type 2 diabetes to migraine, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the first quarter.